Replies to post #54903 on PharmaCyte Biotech Inc (PMCB)

[BioNewton]

There you go. Now you're catching on. PMCB needs clinical trials to confirm that designation. PMCB just submitted the preIND which does not take years as stated incorrectly earlier. PMCB is following the steps towards clinical trials. Let the steps happen.
















This trades at .03 - kind of wasted energy - no homeless to pick on?

[$Pistol Pete$]

WRONG

cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate
Trade Name: N/A
Date Designated: 12/17/2014
Orphan Designation: Treatment of pancreatic cancer in combination with ifosfamide
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date: N/A
Approved Labeled Indication:
Exclusivity End Date: N/A
Sponsor: PharmaCyte Biotech, Inc.
23046 Avenida de la Carlota
Suite 600
Laguna Hills, California 92652
USA

The sponsor address listed is the last reported by the sponsor to OOPD.

[BottomBounce]

$PMCB PharmaCyte Biotech featured in "10 Healthcare Innovations That Will Change the World

http://www.nasdaq.com/article/10-healthcare-innovations-that-will-change-the-world-cm652327